{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-23-000016","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2023-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.185284+00:00","generated_at":"2026-06-19T00:49:35.264840+00:00","sec_items":["3.01","7.01","5.02"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Exicure Receives Nasdaq Delisting Notices, Appoints Three New Directors, Closes Private Placement","bullets":["On Feb 21, 2023, Exicure received Nasdaq notice for non-compliance with compensation committee requirements due to resignation of Jeffrey L. Cleland.","Exicure also received second Nasdaq notice for non-compliance with independent director and audit committee requirements; must submit compliance plan within 45 days.","Effective Feb 24, 2023, board appointed Paul Kang, Hyukku Lee, and Changil Ahn as directors; Elizabeth Garofalo resigned.","Private placement with CBI closed on Feb 24, 2023, issuing 3,400,000 shares at $1.60 per share.","Company believes it can rely on Nasdaq's controlled company exemption for some requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-23-000016","json":"https://secwatch.observer/filing/0001698530-23-000016.json","markdown":"https://secwatch.observer/filing/0001698530-23-000016.md","text":"https://secwatch.observer/filing/0001698530-23-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/xcur-20230221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T00:49:35.264840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"594d8022bf0d4ecc4145afb3bed42116575525b7","claim":"EXICURE, INC. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(d)(4)).","evidence_excerpt":"February 21, 2023, Exicure, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is no longer in compliance with Nasdaq’s compensation committee requirements as set forth in Nasdaq Listing Rule 5605 as a result of the previously disclosed resignation of Jeffrey L. Cleland, Ph.D., effective February 10, 2023 . Nasdaq Rule 5605 requires the compensation committee of the board of directors to be comprised of at least two independent directors (the “Listing Requirement for Compensation Committee”). Pursuant to Nasdaq Listing Rules 5605(d)(4), the Compan","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"board independence"},{"label":"Rules","value":"5605, 5605(d)(4)"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"5edd9c853f","claim":"Changil Ahn was appointed as Class III Director at EXICURE, INC..","evidence_excerpt":"the Board appointed Paul Kang, Hyukku Lee and Changil Ahn to the Board effective February 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"},{"claim_id":"74a2708e1e","claim":"Paul Kang was appointed as Class III Director at EXICURE, INC..","evidence_excerpt":"the Board appointed Paul Kang, Hyukku Lee and Changil Ahn to the Board effective February 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"},{"claim_id":"b876c13e66","claim":"Elizabeth Garofalo resigned as Director and Chair of the Board at EXICURE, INC..","evidence_excerpt":"Effective February 24, 2023, following closing of the Private Placement, Elizabeth Garofalo, M.D. resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) and as chair of the Board as well as from the audit committee, compensation committee and nominating and corporate governance committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Chair of the Board"}],"fact_type":"executive_change"},{"claim_id":"d485fb8116","claim":"Hyukku Lee was appointed as Class II Director at EXICURE, INC..","evidence_excerpt":"the Board appointed Paul Kang, Hyukku Lee and Changil Ahn to the Board effective February 24, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853023000016/0001698530-23-000016-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}